1.0 investigating the role of sqstm1 (p62) in ... · methods: derivation of human cortical neurons...
TRANSCRIPT
Introduction
Mitochondrial dysfunction is a common feature of numerous
neurodegenerative diseases. Furthermore, several disease-associated
mutations have been identified in genes regulating the selective
degradation of damaged mitochondria by autophagy (aka mitophagy),
suggesting the involvement of mitophagy in driving disease
pathogenesis. Selective mitophagy is critically important for neuronal
survival as it maintains an optimal cellular energy production whilst
avoiding the toxic accumulation of damaged/ dysfunctional
mitochondria, which can lead to cell death. The discovery of mutations
in the PINK1 and PRKN (Parkin) genes in Parkinson’s disease has
facilitated mechanistic understanding of the mitophagy process. For
inducing selective mitophagy, PINK1 and PRKN interact with various
autophagic adaptor proteins including SQSTM1 (p62), which has been
shown to be mutated in patients with frontotemporal dementia (FTD).
The precise role of SQSTM1 in mitochondrial function and clearance
remains to be clarified. In particular, it is unclear whether SQSTM1 is
essential in neuronal mitophagy. To address this knowledge gap, we
are assessing the importance of mitophagy in human iPSC derived
neurons with or without genetic alterations in SQSTM1.
Result 2: Generation of iPSCs lacking SQSTM1
Result 3: The differentiation capacity of iPSCs into cortical
neurons appears unaffected by the loss of SQSTM1.
Result 5: Depletion of SQSTM1 results in reduced
expression of genes involved in the respiratory chain
and impairs mitochondrial respiration in human iPSC-
derived cortical neurons.
Result 7: Mitochondrial PINK1 recruitment and loss of
mitochondria in iPSC-derived cortical neurons occur in
the absence of SQSTM1 following mitochondrial
depolarization.
Conclusions and Future Direction
Increase in PINK1 localization to the
mitochondria after 18h of oligomycin
and antimycin (O+A) treatment and
mitochondrial fractionation →
Investigating the role of SQSTM1 (p62) in mitochondrial function and
clearance in cortical neurons
Figure 1. SQSTM1 (p62) has been identified as an adaptor for
mitophagy (Martinez-Vicente 2017, Shahheydari et al., 2017).
Mutations have been shown to be causative for FTD/ALS.
Result 1: SQSTM1 is expressed in both axons and
dendrites of human iPSC-derived cortical neurons.
SQSTM1 / MAP2 / DAPI 50µm
◦ SQSTM1 is a regulator of mitochondrial respiratory chain function.
◦ Despite its important role in autophagy, SQSTM1 is not essential for the clearance of
damaged mitochondria/ mitophagy.
◦ Future work will examine other arms of the autophagy pathway and cargo
removal mediated by SQSTM1 in our human neuronal model.
Clearance of depolarised mitochondria as indicated by the depletion of mitochondrial proteins in
whole neuron lysates following 36-62h O+A treatment ↓
Aim 1: Generate in vitro human neuron model lacking SQSTM1
Methods: Derivation of human cortical neurons from induced pluripotent stem cells
(iPSCs) from SQSTM1 knockout (KO) and wild type (WT) lines.
Suppliers of WT (RBi001-A) line: Roslin Cells Limited and the European Bank for
induced pluripotent Stem Cells.
Aim 2: Determine the effect of SQSTM1 depletion on mitochondrial function in cortical neurons
Methods: Seahorse XFe96 mitochondria respiration assay, MitoTracker, RNA-Seq.
Methods: induction of mitophagy using 2µM oligomycin and 1µM of antimycin,
mitochondrial enrichment, immunoblotting, real-time PCR to assess mtDNA level.
Aim 3: Assess the effect of SQSTM1 depletion on mitophagy in cortical neurons
SQSTM1 / MAPT(Tau) / DAPI
50µm
SQSTM1/ Hoechst 33342
Non
-edi
ted
WT
SQ
ST
M1
KO
SQSTM1/ Hoechst 33342
50µm
50µm
BCL11B(CTIP-2) / TUBB3(TUJ1) / DAPI
WT
KO
50µm
50µm
SLC17A7(VGLUT1) / TUBB3(TUJ1) / DAPI
WT
KO
50µm
50µm
MitoTracker Deep Red FM / TUBB3(TUJ1) / DAPI
WT
KO
50µm
50µm50µm
Anna Poon1, Gregory A. O’Sullivan1, Hélène Plun-Favreau2, Selina Wray2, Lee Dawson*, & James McCarthy1
1Astex Pharmaceuticals, 436 Cambridge Science Park, Milton Road, Cambridge, CB4 0QA, UK2Institute of Neurology, UCL, London, WC1N 3BG, UK
Project Overview
Poster presented at the 14th International Conference on Alzheimer's and Parkinson's Diseases. Poster available to download from Astex’s website at www.astx.com
* The current affiliation of co-author L.D. is Cerevance, UK.
© Astex Pharmaceuticals
Result 6: Depletion of SQSTM1 reduces autophagy flux
with less LC3-II accumulation in iPSC-derived cortical
neurons following autophagy inhibition.
10µm
10µm
Result 4: Depletion of SQSTM1 does not appear to
significantly alter mitochondrial biogenesis and
distribution in iPSC-derived cortical neurons.
-10.0
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
OC
R (
pm
ol/
min
/Nu
cle
ic
Ac
id)
Basal
0.0
10.0
20.0
30.0
40.0
50.0
60.0
OC
R
(pm
ol/
min
/Nu
cle
ic …
ATP Production
0.0
50.0
100.0
150.0
200.0
250.0
300.0
350.0
OC
R
(pm
ol/
min
/Nu
cle
ic …
Maximal Respiration
0.0
100.0
200.0
300.0
OC
R
(pm
ol/
min
/Nu
cle
ic …
Spare Respiratory
Capacity*P=0.0285 *P=0.0091
p=0.0019
p=0.0026
DM
SO
36h O+A
48h O+A
60h O+A
DM
SO
36h O+A
48h O+A
60h O+A
0.0
0.5
1.0
Fo
ld c
han
ge o
f T
OM
M20
leve
ls c
om
pare
d t
o D
MS
O
WT SQSTM1 KO
p=0.0154
p=0.0022
p=0.0085
p=0.0021
p=0.0004
p=0.0003
DM
SO
36h O+A
48h O+A
60h O+A
DM
SO
36h O+A
48h O+A
60h O+A
0.0
0.5
1.0
Fo
ld c
han
ge o
f T
IM23
levels
co
mp
are
d t
o D
MS
O
WT SQSTM1 KO
p=0.0002
p<0.0001
p<0.0001
p<0.0001
DM
SO
36h O
+A
48h O
+A
62h O
+A
0
20000
40000
60000
80000
MtD
NA
C
op
y N
um
ber
WT
P<0.0001
P<0.0001
P<0.0001
DM
SO
36h O
+A
48h O
+A
62h O
+A
0
500
1000
1500
2000
MtD
NA
C
op
y N
um
ber
SQSTM1 KO
P=0.0035
P=0.0065
P=0.0016 ← Mitochondrial clearance as
indicated by the depletion in
mitochondrial DNA relative to
nuclear DNA in neurons following
36-62h O+A treatment.
WT
SQSTM1 KO
0
5
10
15
20
Full Medium
LC
3-I
I / β
-Acti
n
p=0.0308
WT
SQSTM
1 KO
0
1
2
3
4
Starvation Medium
LC
3-I
I / β
-Acti
n
TBR1 / TUBB3(TUJ1) / DAPI
WT
KO
50µm
50µm
← Alteration in
expression levels of
several genes
associated with cortical
development suggests
SQSTM1 may
modulate neuronal
subtype specification
in the cerebral cortex
(* p< 0.05).
Complex IIComplex I
ND
UFA
6N
DU
FS
4TIM
MD
C1
SD
HA
F4
SD
HA
F3
ETFA
CY
CS
CO
X18
CO
X7A
2LC
OX
6A1
CO
X4I
1A
TP
5F1E
ATP
5MC
2A
TP
5PB
ATP
5F1A
ATP
5MC
3A
TP
5PD
SLC
25A
14
0.0
0.5
1.0
Rela
tiv
e t
ran
scri
pt
leve
ls
WT
SQSTM1 KO
Complex IV Complex V UCP
* * * * * * * * * * * * * * * * * *
* p< 0.05
(KO compared to WT)
Mitochondrial
BiogenesisMtDNA
Maintenance
Mitochondrial
Translation
PPARG
C1A
PPARG
C1B
PPARG
NRF1
MPV17
PO
LG
PNPT1
SSBP1
MRPL4
MRPL9
MRPL15
MRPL19
MRPL23
MRPL37
MRPL41
MRPL46
MRPL47
MRPL48
MRPL50
EEF1A
1
TSFM
LARS2
TRM
U
0.0
0.5
1.0
1.5
Rela
tiv
e t
ran
scri
pt
leve
ls
WT
SQSTM1 KO
* * p< 0.05
(KO compared to WT)
MAP2
MAPT
TUBB3
DLG
4SYP
RBFO
X3
RELN
CUX1
PO
U3F
2
BCL11
B
FOXP2
SATB
2
TBR1
NEURO
G2
FEZF2
RO
RB
PAX6
EM
X2
FOXG
1
0
1
2
3
Rela
tiv
e t
ran
scri
pt
leve
ls
WT
SQSTM1 KO
Pan neuronal Cortical
*
* *
* * * *
*
*
Figure source: Martinez-Vicente 2017